Page 1 | Search Results | Blood | American Society of Hematology

1-17 of 17

Sort by

Sort Order Select

Journal Articles

Higher CD34+ Cell Doses Correlate with Reduced Incidence of Relapse and Better Event-Free Survival after KIR-Ligand Mismatch Cord Blood Transplantation for Childhood Acute Myeloid Leukemia

Hisashi Ishida, Yuta Kawahara, Daisuke Tomizawa, Yasuhiro Okamoto, Yuko Cho, Katsuyoshi Koh, Yuhki Koga, Asahito Hama, Maho Sato, Kiminori Terui, Naoyuki Miyagawa, Akihiro Watanabe, Junko Takita, Koji Kato, Kimikazu Matsumoto, Moeko Hino, Ken Tabuchi, Hirotoshi Sakaguchi

Blood (2023) 142 (Supplement 1): 2843.

https://doi.org/10.1182/blood-2023-174310

Published: 2023

Journal Articles

Outcomes of Hematopoietic Cell Transplantation for Patients with Refractory Cytopenia with Multilineage Dysplasia: A Comparison Children with Adolescents and Young Adults

Blood (2023) 142 (Supplement 1): 2202.

https://doi.org/10.1182/blood-2023-189000

Published: 2023

Journal Articles

Development of a Stacked Ensemble Model for Risk Stratification of Chronic Gvhd after Allogeneic HSCT: Trump Cohort Study

Blood (2023) 142 (Supplement 1): 3561.

https://doi.org/10.1182/blood-2023-173779

Published: 2023

Journal Articles

Prognostic Factors in Children with Acute Myeloid Leukemia Receiving the First Hematopoietic Stem Cell Transplantation in Second Remission

Blood (2022) 140 (Supplement 1): 6075–6076.

https://doi.org/10.1182/blood-2022-158712

Published: 2022

Journal Articles

Hematopoietic Stem-Cell Transplantation in Children with Refractory Acute Myeloid Leukemia

Yasuhiro Okamoto, MD, Kazuko Kudo, MD PhD, Ken Tabuchi, MD, Daisuke Tomizawa, MD PhD, Takashi Taga, MD PhD, Hiroaki Goto, MD, Hiromasa Yabe, MD, PhD, Yozo Nakazawa, MD, PhD, Katsuyoshi Koh, MD, Kazuhiro Ikegame, MD PhD, Nao Yoshida, MD PhD, Naoyuki Uchida, MD PhD, Kenichiro Watanabe, MD PhD, Yuuki Koga, MD PhD, Masami Inoue, MD, Koji Kato, MD PhD, Yoshiko Atsuta, MD PhD, Hiroyuki Ishida, MD, PhD

Blood (2018) 132 (Supplement 1): 4632.

https://doi.org/10.1182/blood-2018-99-111322

Published: 2018

Journal Articles

Hematopoietic Stem Cell Transplantation in Children with Refractory Langerhans Cell Histiocytosis

Kazuko Kudo, MD PhD, Miho Maeda, MD, Nobuhiro Suzuki, MD PhD, Hirokazu Kanegane, MD PhD, Shouichi Ohga, MD PhD, Eiichi Ishii, MD PhD, Yoko Shioda, MD, Toshihiko Imamura, MD PhD, Shinsaku Imashuku, MD PhD, Yukiko Tsunematsu, MD, Mikiya Endo, MD, Akira Shimada, MD PhD, Yuuki Koga, MD PhD, Yoshiko Hashii, MD PhD, Jiro Inagaki, MD, Masami Inoue, MD, Ken Tabuchi, MD, Akira Morimoto, MD PhD

Blood (2018) 132 (Supplement 1): 4657.

https://doi.org/10.1182/blood-2018-99-110711

Published: 2018

Journal Articles

Effect of Age on the Prognosis of Molecular Abnormalities in Pediatric Acute Myeloid Leukemia

Yusuke Hara, MD PhD, Norio Shiba, MD PhD, Genki Yamato, MD PhD, Kentaro Ohki, MD PhD, Manabu Sotomatsu, MD PhD, Ken Tabuchi, MD, Daisuke Tomizawa, MD PhD, Tomohiko Taki, MD PhD, Akitoshi Kinoshita, MD PhD, Nobutaka Kiyokawa, MD PhD, Hirokazu Arakawa, MD PhD, Masabumi Shibuya, MD PhD, Takashi Taga, MD PhD, Akio Tawa, MD PhD, Keizo Horibe, MD PhD, Souichi Adachi, MD PhD, Yasuhide Hayashi, MD PhD

Blood (2018) 132 (Supplement 1): 1506.

https://doi.org/10.1182/blood-2018-99-118097

Published: 2018

Journal Articles

Improved Outcome of Unrelated Cord Blood Transplantation in Children with Severe Aplastic Anemia

Kazuko Kudo, MD PhD, Hideki Muramatsu, MD PhD, Nao Yoshida, MD PhD, Ryoji Kobayashi, MD PhD, Hiromasa Yabe, MD, Mikiya Endo, MD PhD, Masami Inoue, MD PhD, Yozo Nakazawa, MD PhD, Jun-ichi Hara, MD, Shinji Kaminami, MD, Jiro Inagaki, MD, Yoshiko Hashii, MD PhD, Koji Kato, MD PhD, Ken Tabuchi, MD, Seiji Kojima, MD PhD

Blood (2016) 128 (22): 3503.

https://doi.org/10.1182/blood.V128.22.3503.3503

Published: 2016

Journal Articles

NUP98-NSD1 Fusion Gene Is Strongly Associated with a Poor Prognosis in Pediatric Acute Myeloid Leukemia: A Study of the Japanese Childhood AML99 Cooperative Study Group

Norio Shiba, MD, Tomohiko Taki, MD, PhD, Myoung-ja Park, MD, PhD, Chisato Murata, PhD, Kentaro Oki, MD, Hitoshi Ichikawa, PhD, Akira Shimada, MD, PhD, Takashi Kanazawa, MD, PhD, Manabu Sotomatsu, MD, Ken Tabuchi, MD, Souichi Adachi, MD, PhD, Akio Tawa, MD, PhD, Keizo Horibe, MD, PhD, Masahiro Tsuchida, MD, PhD, Ryoji Hanada, MD, Ichiro Tsukimoto, MD., PhD, Hirokazu Arakawa, MD, PhD, Yasuhide Hayashi, MD, PhD

Blood (2011) 118 (21): 1475.

https://doi.org/10.1182/blood.V118.21.1475.1475

Published: 2011

Journal Articles

DEK/NUP214 Fusion Gene Predicts Good Outcome In Acute Myeloid Leukemia In Complete Remission After Allogeneic Hematopoietic Stem Cell Transplantation

Ken Ishiyama, Akiyoshi Takami, Shinji Nakao, Michihiro Hidaka, Tetsuo Maeda, Keisei Kawa, Tokiko Nagamura, Ken Tabuchi, Yoshiko Atsuta, Hisashi Sakamaki

Blood (2010) 116 (21): 2386.

https://doi.org/10.1182/blood.V116.21.2386.2386

Published: 2010

Journal Articles

The Prognosis of Karyotypic Subgroups in Pediatric Acute Myeloid Leukemia Depends on the Alterations of KIT , MLL and FLT3 Genes: A Report from Japanese Childhood AML Cooperative Study Group.

Akira Shimada, MD, Tomohiko Taki, MD, Ken Tabuchi, MD, Ryoji Hanada, MD, Akio Tawa, MD, Masahiro Tsuchida, MD, Keizo Horibe, MD, Ichiro Tsukimoto, MD, Yasuhide Hayashi, MD

Blood (2006) 108 (11): 2281.

https://doi.org/10.1182/blood.V108.11.2281.2281

Published: 2006

Journal Articles

KIT mutations, and not FLT3 internal tandem duplication, are strongly associated with a poor prognosis in pediatric acute myeloid leukemia with t(8;21): a study of the Japanese Childhood AML Cooperative Study Group

Akira Shimada, Tomohiko Taki, Ken Tabuchi, Akio Tawa, Keizo Horibe, Masahiro Tsuchida, Ryoji Hanada, Ichiro Tsukimoto, Yasuhide Hayashi

Blood (2006) 107 (5): 1806–1809.

https://doi.org/10.1182/blood-2005-08-3408

Published: 2006

Includes: Supplemental data

Journal Articles

Tandem Duplications of the FLT3 and MLL Are Independent Poor Prognostic Factors in Pediatric Acute Myeloid Leukemia. AML99 Study in Japan.

Akira Shimada, MD, Tomohiko Taki, MD, Ken Tabuchi, MD, Takeshi Taketani, MD, Ryoji Hanada, MD, Akio Tawa, MD, Masahiro Tsuchida, MD, Keizo Horibe, MD, Ichiro Tsukimoto, MD, Yasuhide Hayashi, MD

Blood (2005) 106 (11): 2779.

https://doi.org/10.1182/blood.V106.11.2779.2779

Published: 2005

Journal Articles

Results of the Japanese Childhood Acute Myeloid Leukemia 99 Protocol for Down Syndrome and Acute Myeloid Leukemia.

Kazuko Kudo, Seiji Kojima, Ken Tabuchi, Eisaburo Ishii, Hiromasa Yabe, Akio Tawa, Masue Imaizumi, Ryoji Hanada, Kazuko Hamamoto, Ryoji Kobayashi, Akira Morimoto, Hideki Nakayama, Shigeru Tsuchiya, Masahiro Tsuchida, Keizo Horibe, Ichiro Tsukimoto

Blood (2005) 106 (11): 276.

https://doi.org/10.1182/blood.V106.11.276.276

Published: 2005

Journal Articles

Repetitive Cycles of High-Dose Cytarabine Are Effective for Childhood Acute Myeloid Leukemia (AML): Long Term Outcome of the Children with AML Treated on Two Consecutive Trials of Tokyo Children’s Cancer Study Group.

Daisuke Tomizawa, MD, Ken Tabuchi, MD, Akitoshi Kinoshita, MD, Ryoji Hanada, MD, Hisato Kigasawa, MD, Ichiro Tsukimoto, MD, Masahiro Tsuchida, MD

Blood (2005) 106 (11): 888.

https://doi.org/10.1182/blood.V106.11.888.888

Published: 2005

Journal Articles

Excellent Outcome of Risk Stratified Treatment for Childhood Acute Myeloid Leukemia-AML99 Trial. For the Japanese Childhood AML Cooperative Study Group.

Ichiro Tsukimoto, MD, Akio Tawa, MD, Ryoji Hanada, MD, Ken Tabuchi, MD, Hisato Kigasawa, MD, Shigeru Tsuchiya, MD, Masahiro Tsuchida, MD, Hiromasa Yabe, MD, Hideki Nakayama, MD, Kazuko Kudo, MD, Ryoji Kobayashi, MD, Kazuko Hamamoto, MD, Masue Imaizumi, MD, Akira Morimoto, MD, Keizo Horibe, MD

Blood (2005) 106 (11): 889.

https://doi.org/10.1182/blood.V106.11.889.889

Published: 2005

Journal Articles

Internal Tandem Duplication and Kinase Domain Mutation of FLT3 in Pediatric Acute Myeloid Leukemia Treated on Japan Cooperative AML 99 Protocol.

Akira Shimada, MD, Takeshi Taketani, MD, Tomohiko Taki, MD, Ken Tabuchi, MD, Ryoji Hanada, MD, Akio Tawa, MD, Masahiro Tsuchida, MD, Keizo Horibe, MD, Ichiro Tsukimoto, MD, Yasuhide Hayashi, MD

Blood (2004) 104 (11): 3010.

https://doi.org/10.1182/blood.V104.11.3010.3010

Published: 2004

NARROW

Higher CD34+ Cell Doses Correlate with Reduced Incidence of Relapse and Better Event-Free Survival after KIR-Ligand Mismatch Cord Blood Transplantation for Childhood Acute Myeloid Leukemia

Outcomes of Hematopoietic Cell Transplantation for Patients with Refractory Cytopenia with Multilineage Dysplasia: A Comparison Children with Adolescents and Young Adults

Development of a Stacked Ensemble Model for Risk Stratification of Chronic Gvhd after Allogeneic HSCT: Trump Cohort Study

Prognostic Factors in Children with Acute Myeloid Leukemia Receiving the First Hematopoietic Stem Cell Transplantation in Second Remission

Hematopoietic Stem-Cell Transplantation in Children with Refractory Acute Myeloid Leukemia

Hematopoietic Stem Cell Transplantation in Children with Refractory Langerhans Cell Histiocytosis

Effect of Age on the Prognosis of Molecular Abnormalities in Pediatric Acute Myeloid Leukemia

Improved Outcome of Unrelated Cord Blood Transplantation in Children with Severe Aplastic Anemia

NUP98-NSD1 Fusion Gene Is Strongly Associated with a Poor Prognosis in Pediatric Acute Myeloid Leukemia: A Study of the Japanese Childhood AML99 Cooperative Study Group

DEK/NUP214 Fusion Gene Predicts Good Outcome In Acute Myeloid Leukemia In Complete Remission After Allogeneic Hematopoietic Stem Cell Transplantation

The Prognosis of Karyotypic Subgroups in Pediatric Acute Myeloid Leukemia Depends on the Alterations of KIT , MLL and FLT3 Genes: A Report from Japanese Childhood AML Cooperative Study Group.

KIT mutations, and not FLT3 internal tandem duplication, are strongly associated with a poor prognosis in pediatric acute myeloid leukemia with t(8;21): a study of the Japanese Childhood AML Cooperative Study Group

Tandem Duplications of the FLT3 and MLL Are Independent Poor Prognostic Factors in Pediatric Acute Myeloid Leukemia. AML99 Study in Japan.

Results of the Japanese Childhood Acute Myeloid Leukemia 99 Protocol for Down Syndrome and Acute Myeloid Leukemia.

Repetitive Cycles of High-Dose Cytarabine Are Effective for Childhood Acute Myeloid Leukemia (AML): Long Term Outcome of the Children with AML Treated on Two Consecutive Trials of Tokyo Children’s Cancer Study Group.

Excellent Outcome of Risk Stratified Treatment for Childhood Acute Myeloid Leukemia-AML99 Trial. For the Japanese Childhood AML Cooperative Study Group.

Internal Tandem Duplication and Kinase Domain Mutation of FLT3 in Pediatric Acute Myeloid Leukemia Treated on Japan Cooperative AML 99 Protocol.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only